Technology | December 13, 2011

Siemens' SAFIRE Iterative Reconstruction Protocol Cleared by FDA

December 13, 2011 — Siemens announced its computed tomography (CT) iterative reconstruction algorithm SAFIRE – Sinogram Affirmed Iterative Reconstruction – has been cleared for domestic sale by the U.S. Food and Drug Administration (FDA). This new generation of image reconstruction software and hardware allows for a robust reduction of radiation dose in CT examinations.

Additionally, the use of projection raw data during the iterative image improvement process enables a reduction of subtle image artifacts; this provides a further improvement in general image quality.

SAFIRE helps users reduce dose by up to 60 percent compared to previous filtered back projection techniques, as documented in the FDA clearance letter.

“From a clinical perspective, SAFIRE helps to significantly reduce radiation exposure across the whole portfolio of clinical applications,” said Elliot Fishman, M.D., CT section chief of radiology at Johns Hopkins Medical Institutions in Baltimore, and a member of the SIERRA (Siemens Radiation Reduction Alliance) dose expert panel.

The extremely fast reconstruction speed of 20 images per second enables reconstruction of a typical high-resolution thorax examination of 30 cm in just 15 seconds. With this, the system can be applied routinely in clinical practice.

Unveiled last November at RSNA 2010 as a work-in-progress, SAFIRE is available for Siemens Somatom Definition Flash and Somatom Definition AS CT systems; it will be available on the Definition DS in mid-2012.

In the meantime, the company’s current iterative reconstruction method, IRIS (Iterative Reconstruction in Image Space), will remain available for Somatom Definition dual-source systems. Additionally, due to the overwhelming response to IRIS in the Siemens CT install base, it will be available for Somatom Emotion 16 (2007) and Somatom Sensation 40, 64 and Open CT systems.

Siemens will exhibit in booths #442, 822 and 1642 at RSNA 2011.

For more information: www.siemens.com/healthcare

 

Related Content

The Clear AI software can help with identification coronary plaque features in CT scans that may cause heart attacks. Cleerly Coronary’s noninvasive, AI-driven approach supports the understanding of plaques using FDA-cleared technologies.

The Clear AI software can help with identification coronary plaque features in CT scans that may cause heart attacks. Cleerly Coronary’s noninvasive, AI-driven approach supports the understanding of plaques using FDA-cleared technologies.

News | Computed Tomography (CT) | July 16, 2021
July 16, 2021 — Canon Medical Systems USA is joining forces with Cleerly in a strategic partnership to support simple
The inherent spectral capabilities of Mayo Clinic's new third-generation photon-counting CT research scanner allows clear visualization of the intact portions of the coronary artery lumen (arrowhead) by reducing the bright signal from the dense coronary calcifications (arrows). Spectral CT is able to bin photos on different energies that can be used to enhance or subtract chemical elements based on their spectral signature, such as calcium shown here, and iodine.

The inherent spectral capabilities of Mayo Clinic's new third-generation photon-counting CT research scanner allows clear visualization of the intact portions of the coronary artery lumen (arrowhead) by reducing the bright signal from the dense coronary calcifications (arrows). Spectral CT is able to bin photos on different energies that can be used to enhance or subtract chemical elements based on their spectral signature, such as calcium shown here, and iodine.
 

News | Computed Tomography (CT) | July 14, 2021
July 14, 2021 — Performing the first cardiac scan on their new photon-counting detector...
Illustration of how spectral CT can help confirm findings on a conventional CT scan without requiring follow-up imaging, such as a nuclear scan. The conventional CT on the left, and the dual-energy CT on the right confirms an infarct.

Illustration of how spectral CT can help confirm findings on a conventional CT scan without requiring follow-up imaging, such as a nuclear scan. The conventional CT on the left, and the dual-energy CT on the right confirms an infarct. Image from Philips Healthcare.

Feature | Computed Tomography (CT) | May 27, 2021
May 27, 2021 — Philips Healthcare released a workhorse...
FDA Clears AiCE Image Reconstruction on Canon's Aquilion Precision CT
Technology | Computed Tomography (CT) | October 21, 2019
Canon Medical Systems USA Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance on its Advanced...
FDA Clears Modules of AI-Rad Companion Chest CT From Siemens Healthineers
Technology | Computed Tomography (CT) | September 26, 2019
The U.S. Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent...
Videos | Computed Tomography (CT) | August 07, 2019
This is an example of in-stent restenosis shown using spectral CT imaging.
Achenbach to Receive Inaugural 2019 Stephan Achenbach Pioneer Award in Cardiovascular CT
News | Computed Tomography (CT) | July 10, 2019
The Society of Cardiovascular Computed Tomography (SCCT) will present Stephan Achenbach, M.D., FSCCT with the inaugural...
New Type of Cardiac Care to Cut Imaging Wait Times and Unnecessary Hospital Admissions
News | Computed Tomography (CT) | June 20, 2019
A new type of care for cardiac patients at St. Paul’s Hospital, Vancouver, has the potential to reduce heart imaging...
Canon Medical Receives FDA Clearance for AiCE Reconstruction Technology for CT
Technology | Computed Tomography (CT) | June 18, 2019
Canon Medical Systems USA Inc. has received 510(k) clearance on its new deep convolutional neural network (DCNN) image...